Allogene Therapeutics Announces Publication of Industry-Advancing Case Study on Chromosomal Rearrangement in Molecular Therapy
Publication Reviews Investigation of a Chromosomal Rearrangement Observed in a Single Patient Receiving Gene-Edited Allogeneic CAR T Treatment for Large B Cell LymphomaCase Reveals Normal T Cell Biology Occurring in CAR T Cells, Including Notable Finding ...
Allogene Allo Christine Cassiano David Chang Exchange Commission Allogene Therapeutics Inc Drug Administration
Source: marketscreener.com